- Home
- GAIN vs LAB Comparison
GAIN vs LAB Comparison
Compare GAIN & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GAIN | LAB |
|---|---|---|
| Founded | 2005 | 1999 |
| Country | United States | United States |
| Employees | 70 | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 558.3M | 488.4M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | GAIN | LAB |
|---|---|---|
| Price | $13.97 | $0.96 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $14.75 | $1.35 |
| AVG Volume (30 Days) | 279.2K | ★ 2.4M |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | ★ 10.70% | N/A |
| EPS Growth | N/A | ★ 44.68 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $101,937,000.00 |
| Revenue This Year | $5.67 | N/A |
| Revenue Next Year | $6.44 | $2.63 |
| P/E Ratio | $4.38 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.42 | $0.92 |
| 52 Week High | $15.25 | $1.72 |
Technical Indicators
Market Signals| Indicator | GAIN | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 56.72 | 27.51 |
| Support Level | $13.69 | N/A |
| Resistance Level | $14.17 | $1.41 |
| Average True Range (ATR) | 0.34 | 0.07 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 66.79 | 8.57 |
Price Performance
Historical ComparisonAbout GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.